<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04169373</url>
  </required_header>
  <id_info>
    <org_study_id>M19-944</org_study_id>
    <secondary_id>2019-003229-12</secondary_id>
    <nct_id>NCT04169373</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis</brief_title>
  <acronym>SELECT AXIS 2</acronym>
  <official_title>A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects With Axial Spondyloarthritis Followed by a Remission-Withdrawal Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol includes 2 standalone studies with randomization, data collection, analysis and&#xD;
      reporting conducted independently.&#xD;
&#xD;
      The main objectives of this protocol are:&#xD;
&#xD;
        -  To evaluate the efficacy of upadacitinib compared with placebo on reduction of signs and&#xD;
           symptoms in adult participants with active axial spondyloarthritis (axSpA) including&#xD;
           biologic disease-modifying antirheumatic drug inadequate responders (bDMARD-IR)&#xD;
           ankylosing spondylitis (AS) (Study 1) and non-radiographic axial spondyloarthritis&#xD;
           (nr-axSpA) (Study 2).&#xD;
&#xD;
        -  To assess the safety and tolerability of upadacitinib in adult participants with active&#xD;
           axSpA including bDMARD-IR AS (Study 1) and with nr-axSpA (Study 2).&#xD;
&#xD;
        -  To evaluate the safety and tolerability of upadacitinib in extended treatment in adult&#xD;
           participants with active axSpA including bDMARD-IR AS who have completed the&#xD;
           Double-Blind Period (Study 1) and with nr-axSpA who have completed the Double-Blind&#xD;
           Period (Study 2).&#xD;
&#xD;
        -  To evaluate the maintenance of disease control after withdrawal of upadacitinib.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 26, 2019</start_date>
  <completion_date type="Anticipated">July 3, 2025</completion_date>
  <primary_completion_date type="Actual">September 2, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study 1: Percentage of Participants Achieving Assessment of SpondyloArthritis International Society (ASAS) 40 Response</measure>
    <time_frame>Week 14</time_frame>
    <description>ASAS40 is defined as a &gt;= 40% improvement and an absolute improvement of ≥ 2 units (on a scale of 0 to 10) from Baseline in at least 3 of the 4 domains (patient's global assessment, back pain, function and inflammation) with no worsening at all in the remaining domain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Study 2: Percentage of Participants Achieving Assessment of SpondyloArthritis International Society (ASAS) 40 Response</measure>
    <time_frame>Week 14</time_frame>
    <description>ASAS40 is defined as a &gt;= 40% improvement and an absolute improvement of ≥ 2 units (on a scale of 0 to 10; 0 = no pain and 10 = worst possible pain) from Baseline in at least 3 of the 4 domains (patient's global assessment, back pain, function and inflammation) with no worsening at all in the remaining domain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Ankylosing Spondylitis Disease Activity Score (ASDAS)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The ASDAS is a composite index with proven validity and reliability to assess disease activity in AS patients. It combines the following 5 disease activity variables: back pain, duration of morning stiffness, patient's global assessment (PtGA), peripheral pain/swelling, and high-sensitivity C-reactive protein (hsCRP) or erythrocyte sedimentation rate (ESR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Magnetic Resonance Imaging (MRI) Spondyloarthritis Research Consortium of Canada (SPARCC) Score (Spine)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>SPARCC scores for spine are calculated by adding up the dichotomous outcomes from evaluations of the presence, depth, and intensity of bone marrow edema lesions of the spine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Percentage of Participants With Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) 50 Response</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>BASDAI 50 response is defined as at least 50% improvement from Baseline in the BASDAI. The BASDAI is a commonly used measure to define disease activity levels in axSpA patients. It consists of 6 questions on a 0 through 10 numeric rating scale (NRS) (0 being no problem and 10 being the worst problem) pertaining to the 5 major symptoms of AS: Fatigue, Spinal pain, Joint pain/swelling, Areas of localized tenderness, Morning stiffness duration, and Morning stiffness severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Percentage of Participants With Assessment of SpondyloArthritis International Society (ASAS) 20 Response</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASAS20 is defined as a &gt;= 20% improvement and an absolute improvement of &gt;= 1 units (on a scale of 0 to 10) from Baseline in at least 3 of the 4 domains (patient's global assessment, back pain, function and inflammation) with no deterioration in the remaining domain (where deterioration is defined as a worsening of &gt;= 20% and a net worsening of &gt;= 1 unit [on a scale of 0 to 10]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Percentage of Participants With ASDAS Inactive Disease</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASDAS Inactive Disease is defined as ASDAS score &lt;1.3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Patient's Assessment of Total Back Pain</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>Pain will be measured using 0 - 10 numerical rating scale (NRS) items for Total Back Pain (0 = no pain and 10 = severe pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Patient's Assessment of Nocturnal Back Pain</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>Pain will be measured using 0 - 10 numerical rating scale (NRS) items for Nocturnal Back Pain NRS (0 = no pain and 10 = worst possible pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Percentage of Participants With ASDAS Low Disease Activity</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASDAS Low Disease Activity is defined as ASDAS score &lt;2.1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Bath Ankylosing Spondylitis Functional Index (BASFI)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The BASFI is a validated patient reported outcome (PRO) instrument for use in the AS patient population. It consists of 10 items measured on a 0 to 10 NRS, which assesses the ability to perform activities known to be problematic to AS patients such as dressing, bending, reaching, turning, and climbing steps.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Percentage of Participants With ASAS Partial Remission (PR)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASAS PR is defined as an absolute score of &lt;= 2 units (on a scale of 0 to 10) from Baseline for each of 4 domains (patient's global assessment, back pain, function and inflammation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Ankylosing Spondylitis Quality of Life (ASQoL)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The ASQoL is an 18-item axSpA-specific Quality of Life (QoL) PRO measure validated in the AS patient population. Concepts measured include activities of daily life, emotional functioning, pain, fatigue, and sleep problems. Each item on ASQoL is given a score of &quot;1&quot; or &quot;0,&quot; where a score of &quot;1&quot; is given when an item is affirmed indicating adverse QoL. Total scores can range from 0 (good QoL) to 18 (poor QoL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in ASAS Health Index (HI)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The ASAS HI is validated for patients with all forms of axSpA. It consists of 17 items measuring aspects of functioning and health that are typical and relevant for these patients. Items are scored dichotomously and assess pain, emotional function, sleep, sexual function, mobility, self-care, and community life. Total scores range from 0 (good health) to 17 (poor health), with lower scores indicating better health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Linear Bath Ankylosing Spondylitis Metrology Index (BASMIlin)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The BASMIlin will be conducted at the visits specified to evaluate spinal mobility in a participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in Maastricht Ankylosing Spondylitis Enthesitis Score (MASES)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The MASES evaluation will be conducted by a qualified assessor at the visits specified to assess the presence or absence of enthesitis at 13 different sites noting the participant's responses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 1: Change From Baseline in MRI SPARCC Score (SI Joints)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>SPARCC scores for sacroiliac (SI) joints are calculated by adding up the dichotomous outcomes from evaluations of the presence, depth, and intensity of bone marrow edema lesions of the SI joints.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in ASDAS</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The ASDAS is a composite index with proven validity and reliability to assess disease activity in AS patients. It combines the following 5 disease activity variables: back pain, duration of morning stiffness, patient's global assessment (PtGA), peripheral pain/swelling, and high-sensitivity c-reactive protein (hsCRP) or erythrocyte sedimentation rate (ESR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in MRI SPARCC Score (SI Joints)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>SPARCC scores for sacroiliac (SI) joints are calculated by adding up the dichotomous outcomes from evaluations of the presence, depth, and intensity of bone marrow edema lesions of the SI joints.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Percentage of Participants With BASDAI 50 Response</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>BASDAI 50 response is defined as at least 50% improvement from Baseline in the BASDAI. The BASDAI is a commonly used measure to define disease activity levels in axSpA patients. It consists of a 1 through 10 scale (1 being no problem and 10 being the worst problem) and is used to answer 6 questions pertaining to the 5 major symptoms of AS: Fatigue, Spinal pain, Joint pain/swelling, Areas of localized tenderness, Morning stiffness duration, and Morning stiffness severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Percentage of Participants With ASDAS Inactive Disease</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASDAS Inactive Disease is defined as ASDAS score &lt;1.3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in Patient's Assessment of Total Back Pain</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>Pain will be measured using 0 - 10 numerical rating scale (NRS) items for Total Back Pain (0 = no pain and 10 = severe pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in Patient's Assessment of Nocturnal Back Pain</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>Pain will be measured using 0 - 10 numerical rating scale (NRS) items for Nocturnal Back Pain NRS (0 = no pain and 10 = worst possible pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Percentage of Participants With ASDAS Low Disease Activity</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASDAS Low Disease Activity is defined as ASDAS score &lt;2.1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Percentage of Participants With ASAS PR</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASAS PR is defined as an absolute score of &lt;= 2 units (on a scale of 0 to 10) from Baseline for each of 4 domains (patient's global assessment, pain, function and inflammation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in BASFI</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The BASFI is a validated patient reported outcome (PRO) instrument for use in the AS patient population. It consists of 10 items measured on a 0 to 10 NRS, which assesses the ability to perform activities known to be problematic to AS patients such as dressing, bending, reaching, turning, and climbing steps. The total scores range from 0 to 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in ASQoL</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The ASQoL is an 18-item axSpA-specific Quality of Life (QoL) PRO measure validated in the AS patient population. Concepts measured include activities of daily life, emotional functioning, pain, fatigue, and sleep problems. Each item on ASQoL is given a score of &quot;1&quot; or &quot;0,&quot; where a score of &quot;1&quot; is given when an item is affirmed indicating adverse QoL. Total scores can range from 0 (good QoL) to 18 (poor QoL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in ASAS HI</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The ASAS HI is validated for patients with all forms of axSpA. It consists of 17 items measuring aspects of functioning and health. Items are scored dichotomously and assess pain, emotional function, sleep, sexual function, mobility, self-care, and community life. Total scores range from 0 (good health) to 17 (poor health), with lower scores indicating better health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Percentage of Participants Achieving Assessment of SpondyloArthritis International Society (ASAS) 20 Response</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>ASAS20 is defined as a &gt;= 20% improvement and an absolute improvement of &gt;= 1 units (on a scale of 0 to 10) from Baseline in at least 3 of the 4 domains (patient's global assessment, back pain, function and inflammation) with no deterioration in the remaining domain (where deterioration is defined as a worsening of &gt;= 20% and a net worsening of &gt;= 1 unit [on a scale of 0 to 10]).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in BASMIlin</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The BASMIlin will be conducted at the visits specified to evaluate spinal mobility in a participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in MASES</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>The MASES evaluation will be conducted by a qualified assessor at the visits specified to assess the presence or absence of enthesitis at 13 different sites noting the participant's responses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Change From Baseline in Magnetic Resonance Imaging (MRI) Spondyloarthritis Research Consortium of Canada (SPARCC) Score (Spine)</measure>
    <time_frame>Baseline (Week 0) and Week 14</time_frame>
    <description>SPARCC scores for spine are calculated by adding up the dichotomous outcomes from evaluations of the presence, depth, and intensity of bone marrow edema lesions of the spine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study 2: Percentage of Participants Rescued Between Week 24 and Week 52</measure>
    <time_frame>Week 24 through Week 52</time_frame>
    <description>Participants who do not achieve an ASAS20 response at any 2 consecutive scheduled visits will be rescued with standard of care as described in the protocol.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">734</enrollment>
  <condition>Spondyloarthritis</condition>
  <arm_group>
    <arm_group_label>Study 1: Upadacitinib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be administered upadacitinib for 104 weeks. Participants who flare after 104 weeks will receive open-label upadacitinib once daily from the time of flare for 24 weeks (re-treatment).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study 1: Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be administered placebo for 14 weeks followed by upadacitinib for 90 weeks. Participants who flare after 104 weeks will receive open-label upadacitinib once daily from the time of flare for 24 weeks (re-treatment).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study 2: Upadacitinib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be administered upadacitinib for 104 weeks. Participants who flare after 104 weeks will receive open-label upadacitinib once daily from the time of flare for 24 weeks (re-treatment).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study 2: Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be administered placebo for 52 weeks followed by upadacitinib for 52 weeks. Participants who flare after 104 weeks will receive open-label upadacitinib once daily from the time of flare for 24 weeks (re-treatment).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Upadacitinib</intervention_name>
    <description>Upadacitinib is administered as oral tablet</description>
    <arm_group_label>Study 1: Placebo</arm_group_label>
    <arm_group_label>Study 1: Upadacitinib</arm_group_label>
    <arm_group_label>Study 2: Placebo</arm_group_label>
    <arm_group_label>Study 2: Upadacitinib</arm_group_label>
    <other_name>ABT-494</other_name>
    <other_name>RINVOQ</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for upadacitinib is administered as oral tablet</description>
    <arm_group_label>Study 1: Placebo</arm_group_label>
    <arm_group_label>Study 2: Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Study 1: Participant has the clinical diagnosis of ankylosing spondylitis (AS) who&#xD;
             meet the modified New York Criteria for AS (Study 1); OR&#xD;
&#xD;
          -  Study 2: Participant has the clinical diagnosis of nr-axSpA fulfilling the 2009 ASAS&#xD;
             classification criteria for axSpA but not meeting the radiologic criterion of the&#xD;
             modified New York criteria for AS and have objective signs of active inflammation on&#xD;
             magnetic resonance imaging (MRI) or based on high sensitivity C-reactive protein&#xD;
             (CRP).&#xD;
&#xD;
          -  Study 1 and Study 2: Participant must have a Bath Ankylosing Spondylitis Disease&#xD;
             Activity Index (BASDAI) score ≥ 4 and a Patient's Assessment of Total Back Pain score&#xD;
             ≥ 4 based on a 0 - 10 numerical rating scale at the Screening and Baseline Visits.&#xD;
&#xD;
          -  Study 1: Participants must have had an inadequate response to biologic&#xD;
             disease-modifying antirheumatic drug (bDMARD) therapy.&#xD;
&#xD;
          -  Study 2: Participant with prior treatment with bDMARD-therapy is allowed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant must not have been exposed to Janus Kinase (JAK) inhibitor.&#xD;
&#xD;
          -  Prior bDMARD therapy has to be washed out.&#xD;
&#xD;
          -  Participant must not have a history of an allergic reaction or significant sensitivity&#xD;
             to constituents of the study drug.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ABBVIE INC.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona Arthritis &amp; Rheumatology Associates, P.C. /ID# 215282</name>
      <address>
        <city>Flagstaff</city>
        <state>Arizona</state>
        <zip>86001-6269</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Arthritis and Rheumotology Research, PLLC /ID# 215113</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032-9306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Arthritis &amp; Rheumatology Research, PLLC /ID# 214731</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newport Huntington Medical Group /ID# 216281</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inland Rheum &amp; Osteo Med Grp /ID# 215807</name>
      <address>
        <city>Upland</city>
        <state>California</state>
        <zip>91786</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Denver Arthritis Clinic /ID# 215346</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tekton Research /ID# 215054</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80528</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arthritis &amp; Rheumatic Disease Specialties /ID# 215306</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sweet Hope Research Specialty Inc /ID# 215931</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33016-1897</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Innovation Medical Research Center /ID# 216068</name>
      <address>
        <city>Palmetto Bay</city>
        <state>Florida</state>
        <zip>33157-1737</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Conquest Research /ID# 215804</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Lakes Clinical Trials /ID# 215790</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greater Chicago Specialty Physicians /ID# 216213</name>
      <address>
        <city>Schaumburg</city>
        <state>Illinois</state>
        <zip>60195-3106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Robert Hozman/Clinical Investigation Specialists /ID# 215055</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klein and Associates MD /ID# 214767</name>
      <address>
        <city>Hagerstown</city>
        <state>Maryland</state>
        <zip>21740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center /ID# 215925</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111-1552</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Pharmacology Study Gr /ID# 215293</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University Health Center /ID# 215930</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201-2153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Rheumatology, PC /ID# 214973</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Paul Rheumatology /ID# 215537</name>
      <address>
        <city>Eagan</city>
        <state>Minnesota</state>
        <zip>55121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CenterPointe Institute of Research /ID# 215793</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128-3841</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinvest Research LLC /ID# 215785</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65810-2607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Orthopedic Center /ID# 215594</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016-2772</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Lawrence Health System /ID# 215844</name>
      <address>
        <city>Potsdam</city>
        <state>New York</state>
        <zip>13676</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cape Fear Arthritis Care /ID# 215927</name>
      <address>
        <city>Leland</city>
        <state>North Carolina</state>
        <zip>28451</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marietta Memorial Hospital /ID# 215929</name>
      <address>
        <city>Marietta</city>
        <state>Ohio</state>
        <zip>45750-1635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>STAT Research, Inc. /ID# 215264</name>
      <address>
        <city>Springboro</city>
        <state>Ohio</state>
        <zip>45066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Research of Oklahoma /ID# 215117</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73103-2400</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University /ID# 216446</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altoona Ctr Clinical Res /ID# 214770</name>
      <address>
        <city>Duncansville</city>
        <state>Pennsylvania</state>
        <zip>16635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tekton Research, Inc. /ID# 214923</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Universal Research Associates - Carrollton /ID# 214948</name>
      <address>
        <city>Carrollton</city>
        <state>Texas</state>
        <zip>75007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arth and Osteo Clin Brazo Valley /ID# 215805</name>
      <address>
        <city>College Station</city>
        <state>Texas</state>
        <zip>77845</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JPS Health Network /ID# 215962</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104-4917</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Rheumatology /ID# 216311</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77024-2420</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Biopharma Informatic, LLC /ID# 215885</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Biopharma Informatic - Park Row /ID# 215907</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77084</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Texas Clinical Research /ID# 215928</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79410-1198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Universal Research Associates, Inc /ID# 215189</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75024-5283</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumatology and Pulmonary Clinic /ID# 214946</name>
      <address>
        <city>Beckley</city>
        <state>West Virginia</state>
        <zip>25801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia Research Inst /ID# 214921</name>
      <address>
        <city>South Charleston</city>
        <state>West Virginia</state>
        <zip>25309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Organizacion Medica de Investigacion (OMI) /ID# 214557</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aire</city>
        <state>Ciuadad Autonoma De Buenos Aires</state>
        <zip>1015</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Enfermedades del Hígado y Aparato Digestivo /ID# 214556</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto CAICI /ID# 215242</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Medico Privado de Reumatologia /ID# 214559</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Cordoba /ID# 215846</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Medico Strusberg /ID# 215239</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cimer /Id# 215240</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emeritus Research Sydney /ID# 215507</name>
      <address>
        <city>Botany</city>
        <state>New South Wales</state>
        <zip>2019</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BJC Health /ID# 215510</name>
      <address>
        <city>Paramatta</city>
        <state>New South Wales</state>
        <zip>2150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emeritus Research /ID# 215506</name>
      <address>
        <city>Camberwell</city>
        <state>Victoria</state>
        <zip>3124</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre /ID# 215509</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barwon Rheumatology Services /ID# 215508</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Gent /ID# 215004</name>
      <address>
        <city>Gent</city>
        <state>Oost-Vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Leuven /ID# 215006</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ReumaClinic /ID# 215005</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CMiP - Centro Mineiro de Pesquisa Ltda - ME /ID# 215277</name>
      <address>
        <city>Juiz de Fora</city>
        <state>Minas Gerais</state>
        <zip>36010-570</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EDUMED Educacao em Saude S/S L /ID# 215111</name>
      <address>
        <city>Curitiba</city>
        <state>Parana</state>
        <zip>80440-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMK Sevicos Medicos S/S /ID# 215112</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90480-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto /ID# 215176</name>
      <address>
        <city>Sao Jose Do Rio Preto</city>
        <state>Sao Paulo</state>
        <zip>15090-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CPCLIN - Centro de Pesquisas Clínicas /ID# 215175</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01228-200</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT Kaspela EOOD /ID# 214803</name>
      <address>
        <city>Plovdiv</city>
        <zip>4001</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical center Unimed /ID# 214816</name>
      <address>
        <city>Plovdiv</city>
        <zip>4023</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHAT Plovdiv /ID# 214815</name>
      <address>
        <city>Plovdiv</city>
        <zip>4027</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical center Teodora /ID# 214813</name>
      <address>
        <city>Ruse</city>
        <zip>7012</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical center Excelsior /ID# 214805</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT Sveti Ivan Rilski /ID# 214804</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMHAT Sveti Ivan Rilski /ID# 214806</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnostic consultative center 17 Sofia /ID# 214808</name>
      <address>
        <city>Sofia</city>
        <zip>1505</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Percuro Clinical Research, Ltd /ID# 215302</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8V 3M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital /ID# 215041</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Applied Medical Informatics Research Inc. (AMIR) /ID# 215303</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4A 3T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Recherche Musculo-Squelettique /ID# 215096</name>
      <address>
        <city>Trois-rivières</city>
        <state>Quebec</state>
        <zip>G8Z 1Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de recherche du CHUQ /ID# 215038</name>
      <address>
        <city>Quebec</city>
        <zip>G1R 3S2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of bengbu medical college /ID# 216609</name>
      <address>
        <city>Bengbu</city>
        <state>Anhui</state>
        <zip>233004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anhui Provincial Hospital /ID# 216631</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital /ID# 216545</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital /ID# 216645</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Shantou University Medical College /ID# 217883</name>
      <address>
        <city>Shantou</city>
        <state>Guangdong</state>
        <zip>515041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shenzhen People's Hospital /ID# 225438</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhuzhou Central Hospital /ID# 216644</name>
      <address>
        <city>Zhuzhou</city>
        <state>Hunan</state>
        <zip>412007</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of BaoTou Medical College, Inner Mongolia Universi /ID# 216612</name>
      <address>
        <city>Baotou</city>
        <state>Inner Mongolia</state>
        <zip>014016</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Kunming Medical University /ID# 217945</name>
      <address>
        <city>Kunming</city>
        <zip>650032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital of Fudan University /ID# 216646</name>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Soochow University /ID# 216607</name>
      <address>
        <city>Soochow</city>
        <zip>215006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>REVMACLINIC s.r.o. /ID# 215153</name>
      <address>
        <city>Brno</city>
        <zip>602 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Revmacentrum MUDr. Mostera, s.r.o. /ID# 215161</name>
      <address>
        <city>Brno</city>
        <zip>615 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Revmatologie, s.r.o. /ID# 215309</name>
      <address>
        <city>Brno</city>
        <zip>638 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CCR Ostrava, s.r.o. /ID# 215226</name>
      <address>
        <city>Ostrava</city>
        <zip>702 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ARTHROHELP, s.r.o. /ID# 215224</name>
      <address>
        <city>Pardubice</city>
        <zip>530 02</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Revmatologicky ustav v Praze /ID# 215154</name>
      <address>
        <city>Praha</city>
        <zip>128 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PV MEDICAL Services s.r.o. /ID# 215119</name>
      <address>
        <city>Praha</city>
        <zip>130 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Revmatologicka ambulance - MUDr. Zuzana Urbanova /ID# 215652</name>
      <address>
        <city>Praha</city>
        <zip>140 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomayerova nemocnice /ID# 215118</name>
      <address>
        <city>Praha</city>
        <zip>140 59</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Nemocnice v Motole /ID# 215160</name>
      <address>
        <city>Praha</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MEDICAL PLUS, s.r.o. /ID# 215324</name>
      <address>
        <city>Uherske Hradiste</city>
        <zip>686 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse - Hôtel-Dieu Saint-Jacques /ID# 214780</name>
      <address>
        <city>Toulouse</city>
        <state>Occitanie</state>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux - Hopital Pellegrin /ID# 214784</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Ambroise Pare /ID# 214783</name>
      <address>
        <city>Boulogne Billancourt</city>
        <zip>92104</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hopital Cochin /ID# 214782</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Erlangen /ID# 214281</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumatologische Schwerpunktpraxis Brandt-Juergens /ID# 214282</name>
      <address>
        <city>Berlin</city>
        <zip>12161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 214211</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheuma Research Lausitz, Dr. Mario Sutowicz /ID# 214218</name>
      <address>
        <city>Cottbus</city>
        <zip>30342</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 214207</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxisgemeinschaft Rheumatologie Nephrologie Erlangen /ID# 214212</name>
      <address>
        <city>Erlangen</city>
        <zip>91056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH /ID# 214208</name>
      <address>
        <city>Hamburg</city>
        <zip>20095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover /ID# 214209</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MVZ für Rheumatologie Dr. M. Welcker GmbH /ID# 214261</name>
      <address>
        <city>Planegg</city>
        <zip>82152</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Klinikai Kozpont /ID# 215187</name>
      <address>
        <city>Debrecen</city>
        <state>Hajdu-Bihar</state>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vital-Medicina Kft. /ID# 215182</name>
      <address>
        <city>Veszprém</city>
        <state>Veszprem</state>
        <zip>8200</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehavita Egeszsegkozpont /ID# 215188</name>
      <address>
        <city>Kormend</city>
        <state>Zala</state>
        <zip>9900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Betegapolo Irgalmasrend Budai Irgalmasrendi Korhaz /ID# 215183</name>
      <address>
        <city>Budapest</city>
        <zip>1023</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz /ID# 215186</name>
      <address>
        <city>Gyula</city>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hevizgyogyfurdo es Szent Andras Reumakorhaz /ID# 215184</name>
      <address>
        <city>Heviz</city>
        <zip>8380</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pest Megyei Flor Ferenc Korhaz /ID# 214501</name>
      <address>
        <city>Kistarcsa</city>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CMED Rehabilitacios es Diagnosztikai Kozpont /ID# 215181</name>
      <address>
        <city>Szekesfehervar</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Chaim Sheba Medical Center /ID# 215854</name>
      <address>
        <city>Ramat Gan</city>
        <state>Tel-Aviv</state>
        <zip>5265601</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center /ID# 216956</name>
      <address>
        <city>Tel Aviv-Yafo</city>
        <state>Tel-Aviv</state>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center /ID# 215856</name>
      <address>
        <city>Haifa</city>
        <zip>3339419</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meir Medical Center /ID# 217255</name>
      <address>
        <city>Kfar Saba</city>
        <zip>4428164</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daido Clinic /ID# 214735</name>
      <address>
        <city>Nagoya-shi</city>
        <state>Aichi</state>
        <zip>457-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Matsuyama Red Cross Hospital /ID# 216021</name>
      <address>
        <city>Matsuyama-shi</city>
        <state>Ehime</state>
        <zip>790-8524</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Asahikawa Medical Center /ID# 214930</name>
      <address>
        <city>Asahikawa-shi</city>
        <state>Hokkaido</state>
        <zip>070-8644</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hokkaido University Hospital /ID# 215221</name>
      <address>
        <city>Sapporo-shi</city>
        <state>Hokkaido</state>
        <zip>060-8648</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe University Hospital /ID# 214598</name>
      <address>
        <city>Kobe-shi</city>
        <state>Hyogo</state>
        <zip>650-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine College Hospital /Id# 215638</name>
      <address>
        <city>Nishinomiya-shi</city>
        <state>Hyogo</state>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kita-harima Medical Center /ID# 216069</name>
      <address>
        <city>Ono-shi</city>
        <state>Hyogo</state>
        <zip>675-1327</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuwana City Medical Center /ID# 215196</name>
      <address>
        <city>Kuwana-shi</city>
        <state>Mie</state>
        <zip>511-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nagasaki University Hospital /ID# 215947</name>
      <address>
        <city>Nagasaki-shi</city>
        <state>Nagasaki</state>
        <zip>852-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sasebo Chuo Hospital /ID# 214703</name>
      <address>
        <city>Sasebo-shi</city>
        <state>Nagasaki</state>
        <zip>857-1195</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Okayama Hospital /ID# 214732</name>
      <address>
        <city>Okayama-shi</city>
        <state>Okayama</state>
        <zip>700-8607</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Okinawa Prefectural Chubu Hospital /ID# 215575</name>
      <address>
        <city>Uruma-shi</city>
        <state>Okinawa</state>
        <zip>904-2293</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Osaka Minami Medical Center /ID# 214205</name>
      <address>
        <city>Kawachinagano Shi</city>
        <state>Osaka</state>
        <zip>586-8521</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka City General Hospital /ID# 215640</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka</state>
        <zip>534-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Juntendo University Hospital /ID# 214929</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8431</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.Luke's International Hospital /ID# 215414</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-8560</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital /ID# 214533</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggido</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital /ID# 214297</name>
      <address>
        <city>Seoul</city>
        <state>Seoul Teugbyeolsi</state>
        <zip>04763</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gachon University Gil Medical Center /ID# 214534</name>
      <address>
        <city>Incheon</city>
        <zip>21565</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital /ID# 214532</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyunghee University Hospital at Gangdong /ID# 214296</name>
      <address>
        <city>Seoul</city>
        <zip>05278</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center /ID# 214294</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul St. Mary's Hospital /ID# 214295</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CINTRE, Centro de Investigación y Tratamiento Reumatológico SC /ID# 215217</name>
      <address>
        <city>Mexico City</city>
        <state>Ciudad De Mexico</state>
        <zip>11850</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlemore Clinical Trials /ID# 215502</name>
      <address>
        <city>Papatoetoe</city>
        <state>Auckland</state>
        <zip>2025</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital /ID# 215503</name>
      <address>
        <city>Hamilton</city>
        <state>Waikato</state>
        <zip>3240</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WroMedica I. Bielicka, A. Strzalkowska s.c. /ID# 215093</name>
      <address>
        <city>Wroclaw</city>
        <state>Dolnoslaskie</state>
        <zip>51-685</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nasz Lekarz Przychodnie Medyczne /ID# 214352</name>
      <address>
        <city>Torun</city>
        <state>Kujawsko-pomorskie</state>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>REUMED Sp.z o.o. Filia nr 1 /ID# 214353</name>
      <address>
        <city>Lublin</city>
        <state>Lubelskie</state>
        <zip>20-607</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osteo-Medic S.C. /ID# 214351</name>
      <address>
        <city>Bialystok</city>
        <state>Podlaskie</state>
        <zip>15-351</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ETYKA-Osrodek Badan Klinicznych /ID# 215572</name>
      <address>
        <city>Olsztyn</city>
        <state>Warminsko-mazurskie</state>
        <zip>10-117</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AI Centrum Medyczne Sp. z o.o. sp.k. /ID# 214354</name>
      <address>
        <city>Poznan</city>
        <state>Wielkopolskie</state>
        <zip>61-113</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chelyabinsk Regional Clinical Hospital /ID# 214463</name>
      <address>
        <city>Chelyabinsk</city>
        <state>Chelyabinskaya Oblast</state>
        <zip>454087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Immanuel Kant Baltic Federal University /ID# 218259</name>
      <address>
        <city>Kaliningrad</city>
        <state>Kaliningradskaya Oblast</state>
        <zip>236016</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LLC Family Outpatient Clinic № /ID# 214455</name>
      <address>
        <city>Korolev</city>
        <state>Moskva</state>
        <zip>141060</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Institute of Rheumatology named after V.A. Nasonova /ID# 214459</name>
      <address>
        <city>Moscow</city>
        <state>Moskva</state>
        <zip>115522</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LLC Medical Center /ID# 214410</name>
      <address>
        <city>Novosibirsk</city>
        <state>Novosibirskaya Oblast</state>
        <zip>630099</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nort-Western State Medical University n.a. Mechnikov /ID# 214454</name>
      <address>
        <city>St. Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>193015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LLC Novaya Klinika /ID# 214420</name>
      <address>
        <city>Pyatigorsk</city>
        <state>Stavropol Skiy Kray</state>
        <zip>357500</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Clinic /ID# 214737</name>
      <address>
        <city>Yekaterinburg</city>
        <state>Sverdlovskaya Oblast</state>
        <zip>620109</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central City Hospital #7 /ID# 214741</name>
      <address>
        <city>Yekaterinburg</city>
        <state>Sverdlovskaya Oblast</state>
        <zip>620137</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kazan State Medical University /ID# 214421</name>
      <address>
        <city>Kazan</city>
        <state>Tatarstan, Respublika</state>
        <zip>420012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance Biomedical Ural Group /ID# 214457</name>
      <address>
        <city>Izhevsk</city>
        <state>Udmurtskaya Respublika</state>
        <zip>426061</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olla-Med Clinic /ID# 214460</name>
      <address>
        <city>Moscow</city>
        <zip>105554</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital n.a. O.M. Filatov /ID# 214486</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omsk Regional Clinic Hospital /ID# 214464</name>
      <address>
        <city>Omsk</city>
        <zip>644111</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orenburg State Medical University /ID# 214408</name>
      <address>
        <city>Orenburg</city>
        <zip>460000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ryazan State Medical University named after academician I.P. Pavlov /ID# 214418</name>
      <address>
        <city>Ryazan</city>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RZD-Medicine Saratov /ID# 214465</name>
      <address>
        <city>Saratov</city>
        <zip>410004</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Rheumatologic Hospital No 25 /ID# 214488</name>
      <address>
        <city>St. Petersburg</city>
        <zip>190068</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulyanovsk Regional Clinical Hospital /ID# 214458</name>
      <address>
        <city>Ulyanovsk</city>
        <zip>432017</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univerzitna nemocnica Bratislava Nemocnica Stare Mesto /ID# 214675</name>
      <address>
        <city>Bratislava</city>
        <zip>813 69</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reum.hapi s.r.o. /ID# 224268</name>
      <address>
        <city>Nove Mesto nad Vahom</city>
        <zip>915 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Narodny ustav reumatickych chorob /ID# 214674</name>
      <address>
        <city>Piestany</city>
        <zip>921 12</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MUDr. Zuzana Cizmarikova s.r.o. /ID# 215220</name>
      <address>
        <city>Poprad</city>
        <zip>058 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALBAMED s.r.o. /ID# 215248</name>
      <address>
        <city>Zvolen</city>
        <zip>960 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Marina Baixa /ID# 215970</name>
      <address>
        <city>Villajoyosa</city>
        <state>Alicante</state>
        <zip>03570</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 214967</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Unversitario Marques de Valdecilla /ID# 214965</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Meixoeiro (CHUVI) /ID# 214969</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36213</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia /ID# 214968</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz /ID# 216032</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politecnico La Fe /ID# 214966</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Veterans General Hos /ID# 214332</name>
      <address>
        <city>Kaohsiung</city>
        <state>Taichung</state>
        <zip>81362</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital /ID# 215384</name>
      <address>
        <city>New Taipei City</city>
        <zip>22060</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital /ID# 214019</name>
      <address>
        <city>Taichung City</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung Shan Medical University Hospital /ID# 214018</name>
      <address>
        <city>Taichung</city>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cathay General Hospital /ID# 214183</name>
      <address>
        <city>Taipei</city>
        <zip>10630</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hacettepe Universitesi Tip Fak /ID# 214898</name>
      <address>
        <city>Sihhiye</city>
        <state>Ankara</state>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istanbul University Cerrahpasa Faculty of Medicine /ID# 214895</name>
      <address>
        <city>Cerrahpasa</city>
        <zip>34098</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mugla Sitki Kocman University Medical Faculty /ID# 215358</name>
      <address>
        <city>Mugla</city>
        <zip>48000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Institution L. T. Malaya Therapy National Institution of NAMS of Ukraine /ID# 214155</name>
      <address>
        <city>Kharkiv</city>
        <state>Kharkivska Oblast</state>
        <zip>61039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scientific Research Institute of Invalid Rehabilitation /ID# 214148</name>
      <address>
        <city>Vinnytsia</city>
        <state>Vinnytska Oblast</state>
        <zip>21029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MNPE Chernihiv Regional Hospital of the Chernihiv Region Council /ID# 214145</name>
      <address>
        <city>Chernihiv</city>
        <zip>14029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PNE City Multifunctional Hospital No.18 /ID# 214154</name>
      <address>
        <city>Kharkiv</city>
        <zip>61029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CNCE of Kharkiv Regional Council Regional Clinical Hospital /ID# 214158</name>
      <address>
        <city>Kharkiv</city>
        <zip>61058</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Khmelnytskyi Regional Hospital /ID# 214153</name>
      <address>
        <city>Khmelnytskyi</city>
        <zip>29000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MI Kryvyi Rih City Clinical Hospital No.2 /ID# 214152</name>
      <address>
        <city>Kryvyi Rih</city>
        <zip>50056</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center LLC Institute of Rheumatology /ID# 214146</name>
      <address>
        <city>Kyiv</city>
        <zip>02081</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyiv Railway Clinical Hosp No.2 /ID# 214779</name>
      <address>
        <city>Kyiv</city>
        <zip>03049</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical centre of CONSILIUM MEDICAL LLC /ID# 216234</name>
      <address>
        <city>Kyiv</city>
        <zip>04050</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MNI KRC Kyiv Regional Clinical Hospital /ID# 214156</name>
      <address>
        <city>Kyiv</city>
        <zip>04107</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Non-Commercial Enterprise Odesa Regional Clinical Hospital of the Od /ID# 214159</name>
      <address>
        <city>Odesa</city>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multifield Medical Centre of ONMU /ID# 214149</name>
      <address>
        <city>Odesa</city>
        <zip>65026</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PI &quot;Poltava Regional Clinical Hospital n.a. M.V.Sklifosovsky&quot; /ID# 214151</name>
      <address>
        <city>Poltava</city>
        <zip>36011</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ternopil University Hospital /ID# 214705</name>
      <address>
        <city>Ternopil</city>
        <zip>46002</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MNPE Vinnytsia Regional Clinical Hospital n.a. M.I. Pyrohov /ID# 214147</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21028</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 214865</name>
      <address>
        <city>Norwich</city>
        <state>Norfolk</state>
        <zip>NR4 7UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Suffolk NHS Foundation Trust /ID# 215529</name>
      <address>
        <city>Bury St Edmunds</city>
        <state>Suffolk</state>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust /ID# 214971</name>
      <address>
        <city>Armthorpe Road</city>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lancashire Teaching Hospitals NHS Foundation Trust /ID# 216226</name>
      <address>
        <city>Preston</city>
        <zip>PR2 9HT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Italy</country>
  </removed_countries>
  <link>
    <url>http://www.rxabbvie.com</url>
    <description>Related Info</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 18, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upadacitinib</keyword>
  <keyword>Axial Spondyloarthritis (axSpA)</keyword>
  <keyword>Spondyloarthritis</keyword>
  <keyword>Ankylosing Spondylitis (AS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Upadacitinib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>AbbVie is committed to responsible data sharing regarding the clinical trials we sponsor. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information (e.g., protocols and clinical study reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data requests can be submitted at any time and the data will be accessible for 12 months, with possible extensions considered.</ipd_time_frame>
    <ipd_access_criteria>Access to this clinical trial data can be requested by any qualified researchers who engage in rigorous, independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information on the process, or to submit a request, visit the following link.</ipd_access_criteria>
    <ipd_url>https://www.abbvie.com/our-science/clinical-trials/clinical-trials-data-and-information-sharing/data-and-information-sharing-with-qualified-researchers.html</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

